President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

Sun Pharmaceutical Industries Ltd. closed 11.25% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug ...

Trumps most favoured nation drug policy would negatively impact many Indian pharma companies On Monday, US President Donald Trump signed a new executive order reviving the controversial ‘Most Favored ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Sun Pharmaceutical Industries Ltd. closed 12.86% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Donald Trump’s new drug pricing order has the Indian pharmaceutical industry on edge. While CDMOs may benefit, generics and ...

Special meeting of stockholders to vote on Merger to take place on May 28, 2025 WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) ...

This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.

President Trump's drug pricing order has triggered uncertainty in the pharma sector. Nomura warns Sun Pharma could be hit hardest due to its large US specialty drug exposure, while generics may face ...